Table 2.
Gene/protein | Approach | Phenotypic measurement | Phenotype/result | Pathogen | Ref. |
---|---|---|---|---|---|
clec-17 | RNAi knockdown | infection | hyperdeformed anal region (Dar) response, severe constipation | MN | 53 |
clec-39 | knockout mutant | survival | higher susceptibility | ||
clec-49 | egg laying | lower egg laying | |||
CLEC-39 | ELISA-based assay | binding assays | binding to live/dead pathogen | SM | 55 |
CLEC-49 | with recombinant proteins | ||||
clec-52 | promoter fusion | ||||
reporter | fluorescence | expression in intestine | SA | 52 | |
induction | |||||
promoter fusion | |||||
reporter | fluorescence | expression in intestine | |||
induction | |||||
clec-60 | RNAi knockdown | infection | hyperdeformed anal region (Dar) response, | MN | 53 |
severe constipation | |||||
promoter fusion | |||||
reporter | fluorescence | expression in intestine | SA | 52 | |
induction | |||||
clec-60/61 | overexpression | survival | higher susceptibility | PA | 52 |
cluster | |||||
clec-65 | RNAi knockdown | survival | higher susceptibility | EC | 51 |
clec-67 | promoter fusion | fluorescence | expression in intestine | SE | 56 |
reporter | induction | ||||
clec-70 | RNAi knockdown | survival | higher susceptibility | SA | 52 |
promoter fusion | fluorescence | expression in intestine | |||
reporter | induction | ||||
clec-70/71 | overexpression | survival | higher resistance | SA | 52 |
cluster | higher susceptibility | PA | |||
CLEC-79 | glycoconjugate | binding | binding to Galb1-3GalNAc | 54 | |
microarray | assay | ||||
with recombinant | |||||
protein | |||||
clec-85 | promoter fusion | fluorescence | dependence on immune components | SA | 78 |
reporter | intensity | tir-1, nsy-1, dbl-1, daf-16 | PA | ||
clec-86 | RNAi knockdown | infection | hyperdeformed anal region (Dar) response, | MN | 53 |
severe constipation | |||||
clec-174 | RNAi knockdown | survival | higher susceptibility | VC | 50 |
EC = E. coli strain LF82; SE = S. enterica. For other abbreviations, see the legend to figure 1.